Search

Your search keyword '"Marrosu, Mg"' showing total 424 results

Search Constraints

Start Over You searched for: Author "Marrosu, Mg" Remove constraint Author: "Marrosu, Mg"
424 results on '"Marrosu, Mg"'

Search Results

1. A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients

2. Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis

3. Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

4. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

5. Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs

8. The Italian multiple sclerosis register

9. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

12. Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach

13. Assessing response to interferon-β in a multicenter dataset of patients with MS

14. Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

15. The burden of multiple sclerosis variants in continental Italians and Sardinians

16. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

17. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

18. Multicenter, prospective, observational study aimed at evaluating SAtivex efFEcts (effectiveness and tolerability) in a large population of Italian multiple sclerosis patients: SA. FE. study

19. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

20. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72

21. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene

22. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

23. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

24. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

25. Pregnancy and fetal outcomes after interferonbeta exposure in multiple sclerosis

26. Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis

27. Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study

28. Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans

29. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis

30. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry

31. REPLAY Study Group. Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study.J Child Neurol. 2013 Jul;28(7):849-56. doi: 10.1177/0883073813488828. Epub 2013 May 10

32. Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study

33. ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations

35. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population

36. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study

37. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72

38. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124

39. Trapianto autologo di cellule staminali emolinfopoietiche nella sclerosi multipla

42. Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study

45. Interferon beta therapy and pregnancy outcomes in patients with multiple sclerosis

47. The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study

48. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity

Catalog

Books, media, physical & digital resources